Lazard Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$520K Sell
10,783
-4,286
-28% -$200K ﹤0.01% 1370
2025
Q4
$730K Sell
15,069
-1,615
-10% -$80.1K ﹤0.01% 1246
2025
Q3
$787K Buy
16,684
+11,619
+229% +$561K ﹤0.01% 1215
2025
Q2
$244K Sell
5,065
-155
-3% -$7.92K ﹤0.01% 1653
2025
Q1
$289K Sell
5,220
-1,148
-18% -$62.1K ﹤0.01% 1540
2024
Q4
$306K Sell
6,368
-1,329
-17% -$67.6K ﹤0.01% 1498
2024
Q3
$443K Buy
7,697
+2,660
+53% +$144K ﹤0.01% 1396
2024
Q2
$243K Sell
5,037
-442
-8% -$21.3K ﹤0.01% 1498
2024
Q1
$265K Sell
5,479
-394
-7% -$19.2K ﹤0.01% 1213
2023
Q4
$291K Buy
5,873
+29
+0.5% +$1.42K ﹤0.01% 1271
2023
Q3
$312K Sell
5,844
-5,745
-50% -$306K ﹤0.01% 1258
2023
Q2
$624K Sell
11,589
-431
-4% -$23.2K ﹤0.01% 1068
2023
Q1
$653K Sell
12,020
-116
-1% -$5.64K ﹤0.01% 1067
2022
Q4
$586K Sell
12,136
-1,380,268
-99% -$60.6M ﹤0.01% 1090
2022
Q3
$52.9M Sell
1,392,404
-1,758,576
-56% -$78.4M 0.08% 225
2022
Q2
$158M Sell
3,150,980
-170,741
-5% -$9.06M 0.21% 92
2022
Q1
$171M Buy
3,321,721
+25,457
+0.8% +$1.31M 0.2% 97
2021
Q4
$165M Buy
3,296,264
+90,994
+3% +$4.5M 0.18% 107
2021
Q3
$155M Sell
3,205,270
-50,631
-2% -$2.57M 0.17% 107
2021
Q2
$171M Buy
3,255,901
+203,040
+7% +$10.6M 0.19% 99
2021
Q1
$151M Buy
3,052,861
+28,223
+0.9% +$1.36M 0.18% 104
2020
Q4
$147M Sell
3,024,638
-69,692
-2% -$3.44M 0.19% 106
2020
Q3
$155M Sell
3,094,330
-35,677
-1% -$1.84M 0.22% 94
2020
Q2
$160M Sell
3,130,007
-171,331
-5% -$8.33M 0.25% 89
2020
Q1
$144M Sell
3,301,338
-61,515
-2% -$2.94M 0.26% 82
2019
Q4
$169M Buy
3,362,853
+153,378
+5% +$7.19M 0.24% 91
2019
Q3
$149M Buy
3,209,475
+39,950
+1% +$1.72M 0.24% 96
2019
Q2
$137M Buy
3,169,525
+784,809
+33% +$33.4M 0.22% 97
2019
Q1
$106M Buy
2,384,716
+2,379,716
+47,594% +$102M 0.17% 116
2018
Q4
$217K Hold
5,000
﹤0.01% 858
2018
Q3
$223K Hold
5,000
﹤0.01% 871
2018
Q2
$200K Hold
5,000
﹤0.01% 848
2018
Q1
$200K Hold
5,000
﹤0.01% 843
2017
Q4
$215K Hold
5,000
﹤0.01% 871
2017
Q3
$248K Hold
5,000
﹤0.01% 761
2017
Q2
$239K Hold
5,000
﹤0.01% 756
2017
Q1
$226K Hold
5,000
﹤0.01% 794
2016
Q4
$202K Sell
5,000
-105,200
-95% -$4.14M ﹤0.01% 797
2016
Q3
$4.21M Sell
110,200
-584
-0.5% -$23.4K 0.01% 543
2016
Q2
$4.64M Buy
110,784
+584
+0.5% +$23.9K 0.01% 514
2016
Q1
$4.42M Sell
110,200
-32
-0% -$1.29K 0.01% 509
2015
Q4
$4.7M Buy
110,232
+32
+0% +$1.47K 0.01% 522
2015
Q3
$5.23M Hold
110,200
0.01% 480
2015
Q2
$5.46M Hold
110,200
0.01% 506
2015
Q1
$5.45M Hold
110,200
0.01% 520
2014
Q4
$5.03M Sell
110,200
-251
-0.2% -$12.2K 0.01% 542
2014
Q3
$6.23M Buy
110,451
+16
+0% +$859 0.01% 475
2014
Q2
$5.87M Sell
110,435
-1,687,972
-94% -$89.6M 0.01% 500
2014
Q1
$94M Buy
1,798,407
+172,548
+11% +$8.73M 0.21% 125
2013
Q4
$87.2M Buy
1,625,859
+536,215
+49% +$27.7M 0.19% 123
2013
Q3
$55.2M Sell
1,089,644
-751,358
-41% -$38.2M 0.13% 155
2013
Q2
$94.8M Buy
+1,841,002
New +$98.1M 0.22% 108

Other funds holding SNY

Lazard Asset Management's SNY Position: Q1 2026 in Review

Lazard Asset Management reduced its Sanofi (SNY) stake by 28% in Q1 2026, selling an estimated $200K and leaving 10,783 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

Lazard Asset Management first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $171M in Q2 2021. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Lazard Asset Management held 10,783 shares of Sanofi worth $520K as of Q1 2026.
  • Lazard Asset Management sold 4,286 Sanofi shares in Q1 2026, an estimated $200K.
  • Sanofi made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1370 holding.
  • Lazard Asset Management first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Lazard Asset Management's Sanofi position peaked at $171M in Q2 2021.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.